Mr. Penn joined MVP in 2000 from Boston Millennia Partners, a private equity firm where he was a Partner. From 1994 to 1998, Mr. Penn was President and CEO of Tektagen, Inc., a leading contract services firm serving the biotechnology and pharmaceutical industries. Tektagen was successfully sold to Charles River Laboratories, Inc. in 1998. Prior to Tektagen, Mr. Penn was President of Independence Ventures, Inc., a firm that specialized in starting and building high-potential, technology-based companies. Earlier in his career he held several positions in industry and venture capital.
Mr. Penn is a graduate of the Massachusetts Institute of Technology, the Stanford University Graduate School of Business, and the University of Pennsylvania Law School.